83results about How to "Improve adverse reactions" patented technology

Disclosed are a battery package and a method for charging and discharging secondary batteries including nickel hydrogen batteries by refreshing and suppressing inactivity of the batteries. More concretely, battery package (101) comprises a group of batteries having a plurality of connected secondary batteries, each forming a unit battery, a plurality of sensors for detecting a temperature and a voltage, a display device for displaying a condition of the group of batteries, a switch for controlling charge and discharge of the group of batteries, and an operational control circuit (4) for generating a signal based on signals input from the plurality of sensors to make the display device display the condition of the group of batteries and to activate the switch, wherein the battery package (101) is provided with refreshing demand display device (13) for displaying a need to initiate a refreshing charge and discharge, and it uses the method of carrying out the refreshing charge and discharge automatically when a recovery voltage of the secondary batteries does not exceed a predetermined voltage after a lapse of a predetermined time from a moment when the secondary batteries come to a final discharge voltage. This invention can thus carry out the refreshing charge and discharge even for secondary batteries that become inactive after having been left unused for a long time.

The present invention provides, inter alia, methods for ameliorating an adverse effect in a patient caused by an acute transfusion into the patient of a composition containing aged red blood cells using an iron chelator. Apparatuses and kits for ameliorating such adverse effects are also provided.

The invention relates to a compound fungal polysaccharide preparation having functions of supporting healthy energy, strengthening spleen and stomach and boosting immunity. The preparation is mainly prepared from the following raw materials in percentage by weight: 10-50% of grifola frondosa, 10-50% of hericium erinaceus polysaccharide, 5-35% of ganoderma lucidum polysaccharide and 5-35% of pachymaran. Traditional Chinese medicine holds that supporting healthy energy is to build up healthful vital energy and consolidate essence, namely boosting the immunity, enhancing the disease resistance of a human body, preventing diseases and keeping away from sub-health. The grifola frondosa and the hericium erinaceus polysaccharide medicinal and edible fungal polysaccharides are capable of boosting immunity, protecting gastric mucosa, and improving such adverse reactions of tumor chemotherapy as lack of appetite, emesis, nausea and leucopenia. Traditional Chinese medicine thinks that lucid ganoderma (ganoderma lucidum polysaccharide) and poria cocos (pachymaran) can invigorate qi and strengthen spleen, and calm heart and nerves; modern researches prove that the preparation can boost immunity, resist tumors, assist in cancer therapy, and treat insomnia and dyspepsia. In conclusion, through rational combination of the four fungal polysaccharides, the preparation has clear functions of supporting healthy energy, strengthening spleen and stomach and boosting immunity, and has an obvious healthcare effect on sub-health; meanwhile, the preparation can be used for improving adverse reactions of tumor chemotherapy.

The invention belongs to the field of medicines, and provides a composition used for improving the immune function and a preparation method and application thereof. The active ingredients of the composition are hyaluronic acid or hyalurate and lactobacilli. The composition can improve the organism immune function, the composition is particularly suitable for relieving and treating complications induced by the anti-tumor chemotherapy, and the side effects of chemotherapeutic drugs are reduced.

Each of the disclosed tablet contains Notoginsen triterpenes 25-100mg, lactin 100-415mg, tartaric acid 28-120mg, stevioside 5-20mg, polyethylene glycol 6000 12-50mg, sodium hydrogen carbonate 26-110mg, and magnesium stearate 1-5mg. The preparing process consists of (1) disintegrating and mixing the raw material, making soft material with ethanol, sieving and drying, (2) heating polyethylene glycol 6000, charging sodium hydrogen carbonate, stirring, cooling down and disintegrating, sieving, mixing with the obtained particles and magnesium stearate, (3) pelleting.

The invention discloses an externally used traditional Chinese medicine for treating hyperostosis and rheumatic ostealgia. The medicine comprises a component A and a component B, wherein the component A consists of the following raw materials in parts by weight: 10-30 parts of sangusis draconis, 10-30 parts of pseudo-ginseng, 20-40 parts of drynaria rhizome, 10-30 parts of scorpio, 20-40 parts of safflower carthamus, 20-40 parts of ephedra, 10-30 parts of frankincense, 10-30 parts of angelica sinensis, 10-30 parts of myrrh, 10-30 parts of teasel root and 10-30 parts of ground beetle; the component B consists of the following raw materials in parts by weight: 5-15 parts of white spirit with the alcoholic strength of 30-35 degrees and 10-30 parts of rice vinegar; the weight ratio of the component B to the component A is 1:(5-6). Compared with the prior art, the externally used traditional Chinese medicine disclosed by the invention is simple in components and good in curative effects, and is applicable to patients of each age group; no allergy is caused after taking medicinal liquor or pastes, and the therapy in a course of the treatment cannot be influenced due to inability of drinking wine, so the safety is much higher.

The present invention relates to sodium cefetaxima and sodium tazobactam compound injection preparation. It features that the compound injection preparation consists of sodium cefetaxima and sodium tazobactam in the weight ratio of 5. It has synergetic and accumulated antibacterial effect to drug resisting bacteria strains, strengthened clinical antibacterial effect and no increased negative effect.

The invention relates to a health-care beverage with the function of clearing heat clearing and promoting diuresis and applicable for drinking by diabetic patients. The beverage is made of the following raw materials in parts by weight: 2500 parts of tartary buckwheat, 1500 parts of Portulaca oleracea, 4 parts of stevioside and 50000 parts of pure water. The trying eating experiment demonstrates that no any toxic and side effect is generated while a diabetic patient drinks the beverage for a long time, and the illness condition is bettered; obviously, the material adopted by the beverage is green and natural and is low in cost and the adopted preparation method is green and environment-friendly, so that the beverage is applicable for production and popularization.

The present invention provides a conjugate of tenofovir, addy adefovir and intelligent polymers, a method for preparing the same, and an usage. The invention relates to the technical field that antiviral medicinal molecular tenofovir and addy adefovir are chemical modified, namely, phosphate group of tenofovir or addy adefovir is linked with X group, then X group is linked with intelligent polymers R, or phosphate group of tenofovir or addy adefovir is linked with intelligent polymers R with X function group, and a conjugate of tenofovir, addy adefovir and intelligent polymers with A-X-R-Y formula is formed. The modified tenofovir and addy adefovir forms efficient screen for raw medicine, and improves obviously medicine absorption of intestinal and absorption of cell, improves bioavailability of medicine, at the same time, reduces the kidney cleaning of medicine, and reduces the toxic for kidney, improves security.

Improved therapeutic uses for N-terminal BPI protein products are described in patients that have BPI-reactive anti-neutrophil cytoplasmic antibodies.

The coating agent composition comprises an emulsion containing (A) polydiorganosiloxane having a viscosity of 50 to 10,000,000 mPa·s at 25° C. and having both terminal ends blocked by hydroxyl groups, (B) polyorganohydrogensiloxane having at least three hydrogen atoms bonded to silicon atoms in one molecule, (C) a curing catalyst, and (D) chlorinated polyolefine and/or acryl-modified polyolefine, with which (E) fine spherical particles comprised of a rubber-like elastomer having hardness of less than 90 are mixed to disperse into it. The coating agent composition having good uniform applying property, non tackness, water repellency and lubricating properties and outstanding adhesiveness to a rubber or plastic substrate can be obtained.

Disclosed is a traditional Chinese medicinal preparation as well as a hygienic food preparation for improving life quality of cancer patients, which is prepared from gold buckwheat extract, gen-seng extract by a predetermined proportion.

The invention relates to the field of materials, in particular to a positive electrode active material, a preparation method thereof, a secondary battery positive electrode and a lithium battery. Thepositive electrode active material includes lithium-containing compound particles having a chemical formula of Li1 + xCo1-yMzOu, boron gradiently doped to the lithium-containing compound particles, and nickel gradiently doped to the lithium-containing compound particles. And the contents of boron and nickel are gradually reduced in a gradient manner from the outer surfaces of the lithium-containing compound particles to the inner parts. Due to gradient doping of nickel and boron, the surface activity of Li1+xCo1-yMzOu with a lamellar structure can be obviously reduced. The synergistic effect is achieved on the surfaces of lithium-containing compound particles. The surface activity of the layered lithium cobalt oxide is synergistically reduced, the electronic conductivity of the lithium cobalt oxide material is increased while the stability of the lithium cobalt oxide material is improved, and the dissolution of transition metal on the surface of the layered positive electrode active material in the cycle process under high-temperature and high-pressure conditions is inhibited, so that the capacity retention ratio and the charge-discharge coulombic efficiency of the lithium cobalt oxide material are improved.

A rotating device comprises a hub, a shaft, and a bearing unit. The bearing unit includes a surrounding portion arranged to surround the shaft, and a facing portion arranged to face an end of the shaft. A gap between the shaft and the surrounding portion includes two dynamic pressure generation portions and an intermediate portion arranged between the two dynamic pressure generation portions. The bearing unit further includes a path of a lubricant arranged to connect one side of one dynamic pressure generation portion and the intermediate portion. The shaft and the bearing unit are arranged so that the lubricant pushed out of the other dynamic pressure generation portion towards a gap between the end of the shaft and the facing portion stays in the gap.

The invention relates to dry powder inhalants, in particular to a dry powder inhalant prepared from bufo bufo gargarizans cantor skin extract, the preparation method of the dry powder inhalant and the use of the dry powder inhalant in preparation of medicines for treating lung tumors. The dry powder inhalant is characterized by consisting of bufo bufo gargarizans cantor skin extract and medicallyacceptable auxiliary material in a mass ratio ranging from 1:0 to 1:110. The dry powder inhalant made of the bufo bufo gargarizans cantor skin extract can directly act on lung diseases with less toxic and side reactions and high medicine bioavailability; the dry powder inhalant can overcome the drawbacks of slow effectiveness, undesirable liver firstpass effect, body toxic and side effects, low biological bioavailability and the like; and the dry powder inhalant also can solve the problems of inconvenient use, low obedience in patients and the like of powder injections.

The invention discloses peony face-moistening and nourishing essence and a preparation method thereof. The peony face-moistening and nourishing essence comprises the following raw materials in parts by weight: 65-80 parts of pure water, 2-14 parts of peony flower water, 2-11 parts of glycerol, 3-9 parts of butanediol, 0.05-0.3 parts of sodium hyaluronate, 0.5-1.5 parts of propylene glycol, 0.2-0.8 parts of 1, 2-exylene glycol, 0.01-0.09 parts of disodium EDTA, 0.1-0.7 parts of carbomer, 0.02-0.2 parts of xanthan gum, 0.1-0.5 parts of aminomethyl propanol, 0.001-0.006 parts of 3-o-ethyl ascorbic acid, 1-3 parts of polyethylene glycol-81, 1-2 parts of PEG/PPG-17/6 copolymer, 2-8 parts of nicotinamide, 0.6-1 part of betaine, 0.1-0.8 parts of dipotassium glycyrrhizinate, 0.2-0.8 parts of bis-PEG-15 methyl ether polydimethylsiloxane, 0.11-0.99 parts of p-hydroxyacetophenone, 0.23-0.78 parts of glycosylglycerol, 0.2-0.7 parts of panthenol, 0.001-0.003 parts of peony seed oil, 0.001-0.004 parts of magnolia sieboldii extract, 0.3-1.3 parts of a skin conditioner I, 0.2-1 part of a skin conditioner II, 0.1-0.8 parts of a skin conditioner III, 2-5 parts of a skin conditioner IV, 0.01-0.8 parts of a skin conditioner V and 0.02-0.07 parts of essence.

The present disclosure provides a novel pharmaceutical composition for treating a malignant pleural effusion (MPE), including a benzenesulfonamide derivative and a pharmaceutically acceptable excipient. The present disclosure further provides a method for treating MPE by using the pharmaceutical composition.

The invention provides an internal medial nursing chair for a child. Two installing rods parallel to armrests are symmetrically arranged on the upper portion of the inner side of a chair back of the chair, and check curtains are installed on the installing rods. A protecting band for covering the navel and the stomach of the sick child is arranged on the lower portion of the inner side of the chair back. One end of the protecting band is fixedly connected with the chair back, and the other end of the protecting band is connected with a locating ring on the chair back through a hook in a hanging mode. A medical bag for covering the navel and the stomach of the sick child is arranged in the middle of the protecting band and filled with pharmaceutical compositions. A heating patch pasting position is reserved on the inner side face of the medicine bag. Two perpendicular guide rails are arranged on the inner side of the chair back. A neck pillow is installed on the two perpendicular guide rails through sliding blocks matched with the guide rails. Grooves for containing the arms are formed in the upper end faces of the armrests. Elastic binding bands are arranged above the grooves. By the adoption of the nursing chair, bulges caused by movement of the arms of the sick child can be avoided, auxiliary treatment can be conducted through the medicine bag, and gastrointestinal reaction caused by intravenous drip of erythrocin medicines is reduced.